The evaluation of the impact of biomedical research. Current situation and future perspectives;La evaluación del impacto de la investigación biomédica. Situación actual y perspectivas de futuro

Medicina Clinica

Volumn 131, Issue SUPPL. 5, 2008, Pages 1-5

  García Romero, Antonio ^a,b  

^a UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^b Agencia Lain Entralgo   (Spain)

Author keywords

Biomedical research; Evaluation; Impact

Indexed keywords

ECONOMIC ASPECT; EMPLOYMENT; EVALUATION; KNOWLEDGE; LIFE EXPECTANCY; MEDICAL RESEARCH; QUALITY OF LIFE; SHORT SURVEY; SOCIAL ASPECT;

EID: 68349152445     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/S0025-7753(08)76399-1     Document Type: Article

References (30)

1. Global Forum Health Research. Monitoring financial flows for health research 2008. Disponible en: http://www.globalforumhealth.org/filesupld/MFF08/ monitoringfinancialflows2008.pdf
2. National Science Foundation. Science and Engineering Indicators 2006.
3. A few basic economic facts about research in the medical and related life sciences. Silverstein SC, Garrison HH, Heinig SJ. FASEB J. 1995;9:33-840.
4. Drouin JP, Hediger V, Henke N. Health care costs: A market-based view. McKinsey Quarterly. 2008. Disponible en: http://www.mckinseyquarterly.com /PDFDownload.aspx?L2=12&L3=63&ar=2201&srid=17
5. N.R. Aries, and E.D. Sinclar The economic impact of biomedical research: A case study of voluntary institutions in the New York metropolitan region J Health Politics Policy and Law 23 1998 175 193
6. Lichtenberg FR. Pharmaceutical innovation, mortality reduction and economic growth. NBER Working Paper No. w6569. 1998.
7. Medical and health research. A special Eurobarometer public survey. Bruselas: Comisión Europea; 2007. Disponible en: ftp://ftp.cordis.europa. eu/pub/fp7/docs/ebs-265-en.pdf
8. III Encuesta Nacional sobre Percepción de la Ciencia y la Tecnología. FECYT; 2006. Disponible en: http://www.fecyt.es/fecyt/docs/ tmp/345032001.pdf
9. J.H. Marburguer III Wanted: better benchmarks Science 308 2005 1087
10. David PA, Hall BH, Toole AA. Is public R&D a complement or substitute for private R&D? A review of the econometric evidence. Research Policy. 200;29:497-529.
11. R. Smith Peer review: reform or revolution? BMJ 315 1997 759 760
12. P.O. Seglen Why the impact factor of journals should not be used for evaluating research BMJ 314 1997 498 502
13. Crow M. The Academy as Social Change Driver: Rethinking science, policy and social outcomes. Rethinking science policy. Analytical frameworks for evidence-based policy. SPRU. University of Sussex. NPRNet Conference 2002 'Rethinking Science Policy: Analytical Frameworks for Evidence-Based Policy', March 2002, SPRU, University of Sussex. Brighton: SPRU, 2002.
14. M. Cain, and R. Mitman Diffusion of innovation in health care. I-health Reports 2002 California Health Care Foundation Oakland
15. S.E. Cozzens Socioeconomic impact indicators: Old measures, new models 8th Science and Technology Indicators Conference Leiden 2004
16. Frascati Manual 2002. Proposed standard practice for surveys on research and experimental development. Paris: OCDE; 2002.
17. A.C. Gelijns, N. Rosenberg, and A.J. Moskowitz Capturing the unexpected benefits of medical research N Engl J Med 339 1998 693 698
18. Cutler DM, Deaton AS, Lleras-Muney A. The determinants of mortality. NBER Working Paper No. W11963. 2006.
19. B.R. Martin, and P. Tang The economic and social benefits of publicly funded basic research. Report to the OSI, DTI 2006 SPRU Brighton
20. A. García-Romero Assessing the socio-economic returns of biomedical research (I): How can we measure the relationship between research and health care? Scientometrics 66 2006 249 261
21. B. Ferguson, P. Kelly, A. Georgiou, G. Barnes, B. Sutherland, and B. Woodbridge Assessing payback from NHS reactive research programs J Manage Med 14 2000 25 36
22. Government R&D Funding and Company Behaviour. Paris: OECD; 2006.
23. M. Wehling Translational medicine: science or wishful thinking J Translational Medicine 6 2008 31
24. S. Mankoff, C. Brander, S. Ferrone, and F.M. Marincola Lost in translation: obstacles to translational medicine J Translational Medicine 2 2004 14
25. F. Caron-Flinterman, J.E.V. Broerse, and J.F.G. Bunders Patient partnership in decision-making on biomedical research Science, Technology & Human Values 32 2004 339 368
26. V. Rabeharisoa, and M. Callon The involvement of patients' associations in research Int Soc Sci J 54 2002 57 63
27. E. Elias Zerhouni The NIH Roadmap Science 302 2003 63 72
28. IPTS RTD Evaluation Toolbox Assessing the socio-economic impact of RTD-policies 2002 European Commission Sevilla
29. M. Buxton, S. Hanney, and T. Jones Estimating the economic value to societies of the impact of health research: a critical review Bull WHO 82 2004 733 739
30. R. Smith Measuring the social impact of research. Difficult but necessary BMJ 323 2001 528